222 related articles for article (PubMed ID: 31593221)
1. Selective ETA vs. dual ETA/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats.
Mirabito Colafella KM; Neves KB; Montezano AC; Garrelds IM; van Veghel R; de Vries R; Uijl E; Baelde HJ; van den Meiracker AH; Touyz RM; Danser AHJ; Versmissen J
Cardiovasc Res; 2020 Aug; 116(10):1779-1790. PubMed ID: 31593221
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib, but not indomethacin, ameliorates the hypertensive and perivascular fibrotic actions of cyclosporine in rats: role of endothelin signaling.
El-Mas MM; Helmy MW; Ali RM; El-Gowelli HM
Toxicol Appl Pharmacol; 2015 Apr; 284(1):1-7. PubMed ID: 25656942
[TBL] [Abstract][Full Text] [Related]
3. Selective endothelin A receptor antagonism with sitaxentan reduces neointimal lesion size in a mouse model of intraluminal injury.
Duthie KM; Hadoke PW; Kirkby NS; Miller E; Ivy JR; McShane JF; Lim WG; Webb DJ
Br J Pharmacol; 2015 Jun; 172(11):2827-37. PubMed ID: 25598351
[TBL] [Abstract][Full Text] [Related]
4. A dual blocker of endothelin A/B receptors mitigates hypertension but not renal dysfunction in a rat model of chronic kidney disease and sleep apnea.
Morales-Loredo H; Jones D; Barrera A; Mendiola PJ; Garcia J; Pace C; Murphy M; Kanagy NL; Gonzalez Bosc LV
Am J Physiol Renal Physiol; 2019 May; 316(5):F1041-F1052. PubMed ID: 30810064
[TBL] [Abstract][Full Text] [Related]
5. Vascular Effects of Endothelin Receptor Antagonists Depends on Their Selectivity for ETA Versus ETB Receptors and on the Functionality of Endothelial ETB Receptors.
Iglarz M; Steiner P; Wanner D; Rey M; Hess P; Clozel M
J Cardiovasc Pharmacol; 2015 Oct; 66(4):332-7. PubMed ID: 25992919
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hypertension and renal injury induced by the angiogenesis inhibitor sunitinib: preclinical study.
Lankhorst S; Kappers MH; van Esch JH; Smedts FM; Sleijfer S; Mathijssen RH; Baelde HJ; Danser AH; van den Meiracker AH
Hypertension; 2014 Dec; 64(6):1282-9. PubMed ID: 25185126
[TBL] [Abstract][Full Text] [Related]
7. Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells.
Soldano S; Paolino S; Pizzorni C; Trombetta AC; Montagna P; Brizzolara R; Corallo C; Giordano N; Sulli A; Cutolo M
Clin Exp Rheumatol; 2017; 35(3):484-493. PubMed ID: 28134077
[TBL] [Abstract][Full Text] [Related]
8. Endothelin ET
Vercauteren M; Trensz F; Pasquali A; Cattaneo C; Strasser DS; Hess P; Iglarz M; Clozel M
J Pharmacol Exp Ther; 2017 May; 361(2):322-333. PubMed ID: 28223322
[TBL] [Abstract][Full Text] [Related]
9. Chronic blockade of endothelin A and B receptors using macitentan in experimental renovascular disease.
Tullos NA; Stewart NJ; Davidovich R; Chade AR
Nephrol Dial Transplant; 2015 Apr; 30(4):584-93. PubMed ID: 25438341
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
11. Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertension.
Rothermund L; Kossmehl P; Neumayer HH; Paul M; Kreutz R
J Hypertens; 2003 Dec; 21(12):2389-97. PubMed ID: 14654760
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system blockade alone or combined with ET
Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
[TBL] [Abstract][Full Text] [Related]
13. Effects of systemic and renal intramedullary endothelin-1 receptor blockade on tissue NO and intrarenal hemodynamics in normotensive and hypertensive rats.
Bądzyńska B; Vaneckova I; Sadowski J; Hojná S; Kompanowska-Jezierska E
Eur J Pharmacol; 2021 Nov; 910():174445. PubMed ID: 34492284
[TBL] [Abstract][Full Text] [Related]
14. Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade.
Spiers JP; Kelso EJ; Siah WF; Edge G; Song G; McDermott BJ; Hennessy M
J Hypertens; 2005 Sep; 23(9):1717-24. PubMed ID: 16093917
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 inhibition prevents renal toxicity but not hypertension during sunitinib treatment.
van Dorst DCH; Mirabito Colafella KM; van Veghel R; Garrelds IM; de Vries R; Mathijssen RHJ; Danser AHJ; Versmissen J
Eur J Pharmacol; 2024 Jan; 962():176199. PubMed ID: 38029870
[TBL] [Abstract][Full Text] [Related]
16. The endothelin system in pulmonary arterial hypertension.
Galié N; Manes A; Branzi A
Cardiovasc Res; 2004 Feb; 61(2):227-37. PubMed ID: 14736539
[TBL] [Abstract][Full Text] [Related]
17. Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
Battistini B; Verreault M; Ayach B; Blouin A; Cernacek P; Jeng AY; Wessale J; Opgenorth T; Tsang J
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S386-9. PubMed ID: 15838327
[TBL] [Abstract][Full Text] [Related]
18. The vascular endothelial growth factor receptor inhibitor sunitinib causes a preeclampsia-like syndrome with activation of the endothelin system.
Kappers MH; Smedts FM; Horn T; van Esch JH; Sleijfer S; Leijten F; Wesseling S; Strevens H; Jan Danser AH; van den Meiracker AH
Hypertension; 2011 Aug; 58(2):295-302. PubMed ID: 21670421
[TBL] [Abstract][Full Text] [Related]
19. Blockade of endothelin ET(A), but not thromboxane, receptors offsets the cyclosporine-evoked hypertension and interrelated baroreflex and vascular dysfunctions.
Nasser SA; Elmallah AI; Sabra R; Khedr MM; El-Din MM; El-Mas MM
Eur J Pharmacol; 2014 Mar; 727():52-9. PubMed ID: 24486390
[TBL] [Abstract][Full Text] [Related]
20. Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats.
Hocher B; Rohmeiss P; Zart R; Diekmann F; Vogt V; Metz D; Fakhury M; Gretz N; Bauer C; Koppenhagen K; Neumayer HH; Distler A
Cardiovasc Res; 1996 Apr; 31(4):499-510. PubMed ID: 8689641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
